Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-26T00:23:29.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov release identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T00:34:48.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T00:24:37.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry, v3.7.0, was added to the study history, while the prior revision v3.6.6 was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-20T22:58:03.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the study record history, replacing the previous revision, indicating an updated version of the page data.
    Difference
    0.1%
    Check dated 2026-08-30T21:53:59.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The record history now shows a new revision version v3.6.5, replacing the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-09T11:07:35.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.